Pharmaceutical — Currency translation/Other
Business Segments · Currency translation/OtherJohnson & Johnson Pharmaceutical — Currency translation/Other decreased by 105.2% to -$28.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 109.8%, from $287.00M to -$28.00M.
Analysis
StatementSegment
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ3 2025
How to read this metric
Fluctuations reflect broader macroeconomic trends in currency markets rather than operational performance.
Detailed definition
Represents the net impact of foreign currency exchange rate fluctuations and other miscellaneous adjustments on the good...
Peer comparison
Standard 'Foreign Currency Translation' adjustment found in segment asset roll-forwards for global companies.
Metric ID:
jnj_segment_innovative_medicine_currency_translation_otherHistorical Data
10 periods
| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$262.00M | -$170.00M | $124.00M | -$145.00M | -$57.00M | $287.00M | -$440.00M | $215.00M | $543.00M | -$28.00M |
| QoQ Change | — | +35.1% | +172.9% | -216.9% | +60.7% | +603.5% | -253.3% | +148.9% | +152.6% | -105.2% |
| YoY Change | — | +35.1% | +172.9% | — | -146.0% | — | — | +248.3% | >999% | -109.8% |
Range-$440.00M – $543.00M
CAGR-63.0%
Avg YoY Growth+208.9%
Median YoY Growth+104.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's pharmaceutical — currency translation/other?
- Johnson & Johnson (JNJ) reported pharmaceutical — currency translation/other of -$28.00M in Q3 2025.
- How has Johnson & Johnson's pharmaceutical — currency translation/other changed year-over-year?
- Johnson & Johnson's pharmaceutical — currency translation/other decreased by 109.8% year-over-year, from $287.00M to -$28.00M.
- What does pharmaceutical — currency translation/other mean?
- Changes in the value of Innovative Medicine's goodwill due to currency exchange rates and other non-operational factors.